Sepsis in burn patients
Key Points
- Apply ABA burn-specific sepsis criteria rather than conventional SIRS/Sepsis-3 definitions, which are unreliable in the setting of burn-induced hyperinflammation [1]
- Track platelet count trends daily; a sustained decline below 0.1 x 10^12/L for more than 4 days is strongly associated with sepsis and death in pediatric burns [3]
- Monitor vital sign patterns (temperature spikes, heart rate spikes, MAP dips) as a composite; combination scoring achieves high sensitivity for bloodstream infection [4]
- Trend CRP levels to detect sepsis an average of 2.3 days before clinical recognition, while recognizing limited specificity of isolated CRP elevations [5]
- Pursue early wound excision and enteral nutrition as active sepsis prevention strategies [8]
Overview
Sepsis recognition in burn patients requires burn-specific diagnostic criteria because the hypermetabolic, hyperinflammatory state produced by major thermal injury meets conventional SIRS criteria from the moment of injury. Fever, tachycardia, tachypnea, and leukocytosis, the very criteria that define SIRS in the general population, are baseline findings in major burns [1]. Failing to identify true infection against this inflammatory background is a leading contributor to burn mortality.
Assessment
ABA Consensus Criteria
The American Burn Association consensus conference (2007) produced burn-specific sepsis triggers requiring at least three of the following: temperature greater than 39 C or less than 36.5 C, progressive tachycardia, progressive tachypnea, thrombocytopenia, hyperglycemia, and inability to continue enteral feeds [1]. These criteria represent the most widely referenced definition in burn care and were the first systematic attempt to separate the signal of infection from the noise of burn-related inflammation.
Biomarkers
No single biomarker has proven sufficient as a standalone indicator of sepsis in burn patients. A comprehensive 2025 review examining acute phase reactants, cytokines, inflammatory markers, and emerging omics-based approaches concluded that the future of burn sepsis diagnosis will likely require a panel of biomarkers spanning multiple categories [2].
Platelet count trends: In a study comparing 32 pediatric burn fatalities with 32 matched survivors, 31 of 32 non-survivors developed a platelet count below 0.1 x 10^12/L compared with only 10 survivors. The platelet decline preceded other clinical signs of sepsis in all cases, and sustained thrombocytopenia for more than 4 days was uniformly associated with death [3].
Vital sign pattern scoring: A predictive scoring system using temperature spikes, heart rate spikes, and mean arterial pressure dips in 100 pediatric patients with burns exceeding 20% TBSA achieved 93% sensitivity and 81% specificity for predicting bloodstream infections within a 24-hour window [4].
CRP kinetics: A significant CRP rise (increase of at least 3 mg/dL over 2 days or 10 mg/dL in 1 day, excluding post-burn and post-operative spikes) achieved 100% sensitivity and 69% specificity, with CRP rises preceding clinical sepsis by an average of 2.3 days [5].
Organ Dysfunction Scoring
The Thermal Injury Organ Failure Score (TIOFS) correlated more closely with outcome than APACHE II in 529 burn patients. All but one non-survivor had scores indicating dysfunction of at least three organs, and sepsis was present in 22 of 33 deaths [6].
Emerging Diagnostics
Label-free Raman spectroscopy applied to plasma-derived extracellular vesicles achieved 97.5% sensitivity and 90.0% specificity for sepsis detection in burn patients. Spectral differences traced to glycoconjugates of bacterial strains associated with sepsis morbidity [7].
Management
Early burn excision combined with aggressive enteral feeding significantly reduced wound colonization and the incidence of sepsis compared with delayed treatment, while also attenuating muscle protein catabolism [8]. These data support early excision and enteral nutrition as active sepsis prevention strategies, not just wound management.
Controversies and Evidence Gaps
The ABA consensus criteria, while widely adopted, were derived from expert opinion and retrospective analysis rather than prospective validation studies. Whether procalcitonin adds diagnostic value in burns remains contested: the persistent hypermetabolic state elevates baseline levels, reducing its discriminatory power compared to general ICU populations. The threshold for initiating empiric antibiotics varies significantly between burn centers, with no consensus on whether clinical suspicion alone or biomarker confirmation should trigger treatment. Emerging technologies such as Raman spectroscopy and transcriptomic biomarker panels show promise but require multicenter prospective validation before clinical adoption. The optimal integration of multiple biomarkers into a composite diagnostic panel remains undefined.
References
[1] Greenhalgh DG et al. (2007). American Burn Association consensus conference to define sepsis and infection in burns. PMID: 17925660 [2] Palmieri TL, Heard J. (2025). Biomarkers of sepsis in burn injury: an update. PMID: 39822649 [3] Housinger TA et al. (1993). The relationship between platelet count, sepsis, and survival in pediatric burn patients. PMID: 8418782 [4] Sadeq F et al. (2022). Specific patterns of vital sign fluctuations predict infection and enable sepsis diagnosis in pediatric burn patients. PMID: 35130306 [5] Neely AN et al. (1998). Efficacy of a rise in C-reactive protein serum levels as an early indicator of sepsis in burned children. PMID: 9556309 [6] Saffle JR et al. (1993). Multiple organ failure in patients with thermal injury. PMID: 8222683 [7] O'Toole HJ et al. (2024). Plasma-derived extracellular vesicles (EVs) as biomarkers of sepsis in burn patients via label-free Raman spectroscopy. PMID: 39300768 [8] Hart DW et al. (2003). Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. PMID: 12707540